Reference
Oosterhuis I, et al. Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience Drug Safety : 16 Nov 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01253-5
Rights and permissions
About this article
Cite this article
Dedicated system for COVID-19 vaccine safety surveillance at Lareb. Reactions Weekly 1934, 7 (2022). https://doi.org/10.1007/s40278-022-28388-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-28388-x